RNASEL and Familial prostate cancer: XMRV was first reported to be associated with prostate cancer from patients homozygous for a defective variant of RNase L (R462Q), a regulated endoribonuclease for single-stranded RNA that functions in the antiviral action of interferon (IFN) [1], [2].